Systemic administration of Olvi-Vec in the initial dose escalation cohorts achieved a 71% disease control rate (5/7) with two partial responders. All participants with disease control experienced a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback